Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
A Key Regulator of Postnatal Skeletal Remodeling.- Ectodomain Shedding of Receptor Activator of NF-KB Ligand.- The Negative Role Of Ids In Osteoclastogenesis.- Functional Genetic and Genomic Analysis of Modeled Arthritis.- Dexamethsone Suppresses Bone Formation via the Osteoclast.- Immunologic Regulation Of Bone Development.- Pth Regulates The Hematopoietic Stem Cell Niche In Bone.- Regulation Of Hematopoietic Stem Cells In The Osteoblastic Niche.- The Chemokine Cxcl12 And Regulation Of Hsc And Lymphocyte Development In The Bone Marrow Niche.- Osteoclast Precursor Cells.- Interaction with…mehr
A Key Regulator of Postnatal Skeletal Remodeling.- Ectodomain Shedding of Receptor Activator of NF-KB Ligand.- The Negative Role Of Ids In Osteoclastogenesis.- Functional Genetic and Genomic Analysis of Modeled Arthritis.- Dexamethsone Suppresses Bone Formation via the Osteoclast.- Immunologic Regulation Of Bone Development.- Pth Regulates The Hematopoietic Stem Cell Niche In Bone.- Regulation Of Hematopoietic Stem Cells In The Osteoblastic Niche.- The Chemokine Cxcl12 And Regulation Of Hsc And Lymphocyte Development In The Bone Marrow Niche.- Osteoclast Precursor Cells.- Interaction with estrogen receptors as treatment of arthritis and osteoporosis.- Novel Signaling Pathways And Therapeutic Targets In Osteoclasts.- The Enigmatic Function of TREM-2 in Osteoclastogenesis.- Role of cell-matrix interactions in osteoclast differentiation.- Positive and negative roles of IL-6, STAT3 and SOCS3 in inflammatory arthritis.- Control of Osteoclast activity and bone loss by IKK subunits: new targets for therapy.- Targeting Osteoporosis And Rheumatoid Arthritis By Active Vaccination Against Rankl.- RANKL Inhibition: From Mice to Men (and Women).
Yongwon Choi, University of Pennsylvania, Philadelphia, PA, USA
Inhaltsangabe
Schnurri-3: A Key Regulator of Postnatal Skeletal Remodeling.- Ectodomain Shedding of Receptor Activator of NF-?B Ligand.- The Negative Role of IDS in Osteoclastogenesis.- Functional Genetic and Genomic Analysis of Modeled Arthritis.- Dexamethsone Suppresses Bone Formation via the Osteoclast.- Immunologic Regulation of Bone Development.- PTH Regulates the Hematopoietic Stem Cell Niche in Bone.- Regulation of Hematopoietic Stem Cells in the Osteoblastic Niche.- The Chemokine CXCL12 and Regulation of Hsc and B Lymphocyte Development in the Bone Marrow Niche.- Osteoclast Precursor Cells.- Interaction with Estrogen Receptors as Treatment of Arthritis and Osteoporosis.- Novel Signaling Pathways and Therapeutic Targets in Osteoclasts.- The Enigmatic Function of TREM-2 in Osteoclastogenesis.- Role of Cell-matrix Interactions in Osteoclast Differentiation.- Positive and Negative Roles of IL-6, STAT3, and SOCS3 in Inflammatory Arthritis.- Control of Osteoclast Activity and Bone Loss by IKK Subunits: New Targets for Therapy.- Targeting Osteoporosis and Rheumatoid Arthritis by Active Vaccination Against RANKL.- RANKL Inhibition: From Mice to Men (and Women).
Schnurri 3: A Key Regulator of Postnatal Skeletal Remodeling. Ectodomain Shedding of Receptor Activator of NF ?B Ligand. The Negative Role of IDS in Osteoclastogenesis. Functional Genetic and Genomic Analysis of Modeled Arthritis. Dexamethsone Suppresses Bone Formation via the Osteoclast. Immunologic Regulation of Bone Development. PTH Regulates the Hematopoietic Stem Cell Niche in Bone. Regulation of Hematopoietic Stem Cells in the Osteoblastic Niche. The Chemokine CXCL12 and Regulation of Hsc and B Lymphocyte Development in the Bone Marrow Niche. Osteoclast Precursor Cells. Interaction with Estrogen Receptors as Treatment of Arthritis and Osteoporosis. Novel Signaling Pathways and Therapeutic Targets in Osteoclasts. The Enigmatic Function of TREM 2 in Osteoclastogenesis. Role of Cell matrix Interactions in Osteoclast Differentiation. Positive and Negative Roles of IL 6, STAT3, and SOCS3 in Inflammatory Arthritis. Control of Osteoclast Activity and Bone Loss by IKK Subunits: New Targets for Therapy. Targeting Osteoporosis and Rheumatoid Arthritis by Active Vaccination Against RANKL. RANKL Inhibition: From Mice to Men (and Women).
Schnurri-3: A Key Regulator of Postnatal Skeletal Remodeling.- Ectodomain Shedding of Receptor Activator of NF-?B Ligand.- The Negative Role of IDS in Osteoclastogenesis.- Functional Genetic and Genomic Analysis of Modeled Arthritis.- Dexamethsone Suppresses Bone Formation via the Osteoclast.- Immunologic Regulation of Bone Development.- PTH Regulates the Hematopoietic Stem Cell Niche in Bone.- Regulation of Hematopoietic Stem Cells in the Osteoblastic Niche.- The Chemokine CXCL12 and Regulation of Hsc and B Lymphocyte Development in the Bone Marrow Niche.- Osteoclast Precursor Cells.- Interaction with Estrogen Receptors as Treatment of Arthritis and Osteoporosis.- Novel Signaling Pathways and Therapeutic Targets in Osteoclasts.- The Enigmatic Function of TREM-2 in Osteoclastogenesis.- Role of Cell-matrix Interactions in Osteoclast Differentiation.- Positive and Negative Roles of IL-6, STAT3, and SOCS3 in Inflammatory Arthritis.- Control of Osteoclast Activity and Bone Loss by IKK Subunits: New Targets for Therapy.- Targeting Osteoporosis and Rheumatoid Arthritis by Active Vaccination Against RANKL.- RANKL Inhibition: From Mice to Men (and Women).
Schnurri 3: A Key Regulator of Postnatal Skeletal Remodeling. Ectodomain Shedding of Receptor Activator of NF ?B Ligand. The Negative Role of IDS in Osteoclastogenesis. Functional Genetic and Genomic Analysis of Modeled Arthritis. Dexamethsone Suppresses Bone Formation via the Osteoclast. Immunologic Regulation of Bone Development. PTH Regulates the Hematopoietic Stem Cell Niche in Bone. Regulation of Hematopoietic Stem Cells in the Osteoblastic Niche. The Chemokine CXCL12 and Regulation of Hsc and B Lymphocyte Development in the Bone Marrow Niche. Osteoclast Precursor Cells. Interaction with Estrogen Receptors as Treatment of Arthritis and Osteoporosis. Novel Signaling Pathways and Therapeutic Targets in Osteoclasts. The Enigmatic Function of TREM 2 in Osteoclastogenesis. Role of Cell matrix Interactions in Osteoclast Differentiation. Positive and Negative Roles of IL 6, STAT3, and SOCS3 in Inflammatory Arthritis. Control of Osteoclast Activity and Bone Loss by IKK Subunits: New Targets for Therapy. Targeting Osteoporosis and Rheumatoid Arthritis by Active Vaccination Against RANKL. RANKL Inhibition: From Mice to Men (and Women).
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497